Samsung Bioepis wins 4th FDA approval for biosimilar - Yonhap News

Samsung Bioepis wins 4th FDA approval for biosimilar  Yonhap News

By Kim Han-joo SEOUL, July 24 (Yonhap) -- South Korean pharmaceutical firm Samsung Bioep...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases